Legislative Session number- 88

Bill Name: SF1077

3E Relating to human services

ARTICLE 1 - LICENSING

Modifying provisions
relating to chemical and mental health and human services licensing; requiring
providers licensed to provide opioid addiction chemical dependency treatment
services to provide educational information; establishing methadone treatment
program standards for opioid addiction; providing policies and procedures for
exceeding standards in the administrative rule; defining certain terms;
providing regulations for medication orders, drug testing, criteria for
unsupervised use, restrictions for unsupervised or take-home use, restriction
exceptions, guest dosing, data and reporting, and nonmedication treatment
services documentation; requiring review of the board of pharmacy prescription
monitoring program (PMP); requiring department of human services licensed
providers to develop and maintain certain policies and procedures and to develop
and maintain a quality improvement process and plan; specifying certain
notification requirements to placing authorities for clients enrolled in health
care programs

ARTICLE 2 - CHEMICAL AND MENTAL HEALTH

Specifying
eligibility for placement in opioid treatment programs

ARTICLE 3 - CONTROLLED
SUBSTANCES PRESCRIPTION MONITORING PROGRAM

Modifying the definition of
hallucinogen; making conforming additions to schedule I substances; allowing
commissioner of human services controlled substance reporting system data access
for purposes of establishing and implementing a system to determine additional
controlled substance prescriptions for opioid treatment program patients,
requiring treatment center medical director disclosure under certain
conditions
(je)